July 02, 2025CorporateTERUMO ANNOUNCES COMMERCIAL LAUNCH OF THE IMMUCISE™ INTRADERMAL INJECTION SYSTEM
The Latest Materials Financial Results for FYE 3/2025 May 14, 2025 Financial Statements IFRS Financial Results for the Fiscal Year Ended March 31, 2025 (PDF 258.54 KB) Presentation Material GS26 Mid-term Review & Taking on the Challenge of Global CDMO (PDF 4.06 MB) Financial Results for the Fiscal Year Ended March 31, 2025 (PDF 1.18 MB) Financial Results for the Fiscal Year Ended March 31, 2025 (FY2024)(with note) (PDF 385.67 KB) Additional Information Corporate Data File (PDF 613.13 KB) Corporate Data File (Excel 273.18 KB) Q&A Q&A Session at the Financial Results Briefing for the Fiscal Year Ended March 31, 2025 (PDF 251.96 KB) Webcast Listen to the Webcast Financial Statements /investors/library/financial-statements Presentations /investors/library/presentations Terumo Report /investors/library/annual-reports Sustainability /sustainability Corporate Governance /about/governance Consolidated Financial Statements /investors/library/financial Adobe Reader is required for viewing PDF files. Download Adobe Reader
Q&A Session at the Financial Results Briefing for the Fiscal Year Ended March 31, 2025 (PDF 251.96 KB)
Top
Top